İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2007 · article

Low Efficacy Rate of Moxifloxacin Containing Helicobacter pylori Eradication Treatment In an Observational Study in a Turkish Population

Dergi Helicobacter
ISSN1083-4389
YÖKSİS OpenAlex Açık erişim · bronze
Yıl2007
Atıf18OpenAlex
Yüzdelik%88,7
FWCI2,531,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıHelicobacter
  • Katalog eşleşmesi (ISSN)Helicobacter
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND: Standard triple therapy for Helicobacter pylori has an eradication rate of about 50% in Turkey. It may be due to an increased resistance of H. pylori to antibiotics. Therefore, we aimed to investigate the effectiveness of a new second-generation fluoroquinolone, moxifloxacin-containing triple therapy in H. pylori eradication. MATERIAL AND METHODS: This is an open-label, prospective, single-center, pilot study. We studied 71 dyspeptic patients infected with H. pylori diagnosed by both histology and rapid urease test. Out of 71 dyspeptic patients, 64 had non-ulcer dyspepsia and seven had peptic ulcer. Patients received pantoprazole (40 mg b.i.d.) plus moxifloxacin (400 mg/day) and amoxicillin (1000 mg b.i.d.) for 14 days. Eradication was assessed 4 weeks after completing the therapy by histology and rapid urease test. Per-protocol and intention-to-treat eradication rates were determined. RESULTS: The eradication rate was 42.2% for the intention-to-treat analysis and 47.6% for the per-protocol analysis. Of all patients included in the study, 29.5% had side-effects and only 2.8% of the patients discontinued the treatment because of side-effects. Most of the complications were mild and self-limiting. CONCLUSION: Triple therapy with pantoprazole, moxifloxacin, and amoxicillin for 14 days yielded unacceptably low eradication rates. However, using tests of susceptibility to antibiotics, further studies with larger sample sizes are needed to judge these eradication rates of moxifloxacin containing eradication treatment.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

18atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 7 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2009 Triple or Quadruple Tetracycline-Based Therapies Versus Standard Triple Treatment for Helicobacter pylori TreatmentAtıf 34 · OpenAlex
  2. 2009 Triple or Quadruple Tetracycline Based Therapies Versus Standard Triple Treatment for Helicobacter pylori TreatmentAtıf 34 · OpenAlex
  3. 2009 Triple or Quadruple Tetracycline Based Therapies Versus Standard Triple Treatment for Helicobacter pylori TreatmentAtıf 34 · OpenAlex
  4. 2009 Triple or Quadruple Tetracyclinebased Therapies Versus Standard Triple Treatment for Helicobacter Pylori TreatmentAtıf 34 · OpenAlex
  5. 2019 Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studiesAtıf 25 · OpenAlex
  6. 2019 Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studiesAtıf 25 · OpenAlex
  7. 2012 Efficacy of Bismuth-Containing Quadruple Therapy as First-line Treatment for Helicobacter pylori InfectionAtıf 1 · OpenAlex

Yazarlar

5
  1. ORHAN SEZGİN 1
  2. ENGİN ALTINTAŞ MERSİN ÜNİVERSİTESİ 2
  3. ENVER ÜÇBİLEK 3
  4. ANIL TOMBAK 4
  5. TELLİOĞLU BURÇİN 5